InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,284.58
(
-0.37%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bellweather1

Send PM Follow Ignore
Followers 11
Posts 2370
Boards Moderated 0
Alias Born 06/08/2010

bellweather1

Re: DonShimoda post# 7674

Thursday, 05/05/2011 10:48:36 AM

Thursday, May 05, 2011 10:48:36 AM

Post# of 80490
Do you think it's possible they anticipate a combo strategy of an m-tor with another med may work better, and it's keeping them from commiting to a single drug trial, despite the great pII results.

Could it be that they think a multi target strategy(like Cris's) is more viable?

Don't know if anyone has such a trial(another m-tor plus something else, or a multitarget single drug)in the hopper for endo.

Do you?

Thoughts?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up